Inventor · disambiguated record
Xizhong Huang
Also filed as: HUANG XIZHONG
9 granted patents·26 pending applications·18 citations·filing 2002–2025
82Inventor score
Top patents by PatentIndex Score
35 records- 0185US2023398121A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0285US2023405011A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0384US9192663B2Antibodies for epidermal growth factor receptor 3 (HER3)NOVARTIS AG·Filed 2012·Granted Nov 24, 2015·8 cites·8 claims
- 0478US10195208B2Combination therapyNOVARTIS AG·Filed 2015·Granted Feb 5, 2019·5 cites·26 claims
- 0578US2022193079A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0676US2025170134A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0776US2025177402A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0874US9540619B2MELK regulation for the treatment of breast cancerNOVARTIS AG·Filed 2014·Granted Jan 10, 2017·1 cites·7 claims
- 0971US2022280523A1Combination of pi3k inhibitor and c-met inhibitorNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1066US2019046533A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1164US2021008201A1Antibodies for epidermal growth factor receptor 3 (her3)NOVARTIS AG·Filed 2020·Application pending·0 cites
- 1264US2016184311A1Combination Therapy for the Treatment of CancerCHEN YAN·Filed 2014·Application pending·0 cites
- 1363US2020253980A1Combination of pi3k inhibitor and c-met inhibitorNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1462US9675595B2Synergistic combinations of PI3K- and MEK-inhibitorsFRITSCH CHRISTINE·Filed 2012·Granted Jun 13, 2017·1 cites·2 claims
- 1561US2019350935A1Combination of PI3K inhibitor and c-MET inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1659US8961970B2Combination therapyHUANG XIZHONG·Filed 2013·Granted Feb 24, 2015·1 cites·10 claims
- 1759US2019083500A1Combination of PI3K Inhibitor and C-Met InhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1857US8980259B2Combination therapyHUANG XIZHONG·Filed 2013·Granted Mar 17, 2015·1 cites·16 claims
- 1957US2019216924A1Antibodies for epidermal growth factor receptor 3 (her3)NOVARTIS AG·Filed 2018·Application pending·0 cites
- 2054US2015051252A1Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcomaHUANG XIZHONG·Filed 2013·Application pending·0 cites
- 2151US2018085362A1Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2251US2015216870A1Combination of PI3K Inhibitor and C-Met InhibitorCAPONIGRO GIORDANO·Filed 2013·Application pending·0 cites
- 2349US10080800B2Antibodies for epidermal growth factor receptor 3 (HER3)NOVARTIS AG·Filed 2015·Granted Sep 25, 2018·0 cites·9 claims
- 2446USD964036STableware bagHUANG XIZHONG·Filed 2021·Granted Sep 20, 2022·1 cites·1 claims
- 2544US2017073687A1MELK Regulation for the Treatment of Breast CancerHUANG XIZHONG·Filed 2016·Application pending·0 cites
- 2644US2014275089A12-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative DiseasesNOVARTIS AG·Filed 2012·Application pending·0 cites
- 2744US2003103945A1Methods and compositions for stimulating axon regeneration and preventing neuronal cell degenerationFiled 2002·Application pending·0 cites
- 2843US2020101077A1Combination therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2943US2014066474A1Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorFRITSCH CHRISTINE·Filed 2012·Application pending·0 cites
- 3042US2017095463A1Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitorFRITSCH CHRISTINE·Filed 2016·Application pending·0 cites
- 3139US2016151344A1Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcomaHUANG XIZHONG·Filed 2016·Application pending·0 cites
- 3238US2013178479A1Pharmaceutical combinationsCHEN YAN·Filed 2011·Application pending·0 cites
- 3337US2016199365A12-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 Inhibitors for the Treatment of Proliferative DiseasesHUANG XIZHONG·Filed 2016·Application pending·0 cites
- 3435US2017224692A1Combination TherapyHAO HUAIXIANG·Filed 2015·Application pending·0 cites
- 3534US9532982B2Pharmaceutical combination comprising a phosphatidylinositol 3-kinase inhibitor and/an aromatase inhibitorGOLDBRUNNER MICHAEL·Filed 2013·Granted Jan 3, 2017·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Xizhong Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →